Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Fgf5em1/Cya
Common Name:
Fgf5-KO
Product ID:
S-KO-02044
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Fgf5-KO
Strain ID
KOCMP-14176-Fgf5-B6J-VA
Gene Name
Fgf5
Product ID
S-KO-02044
Gene Alias
Fgf-5; Fgf3a; HBGF-5; angora; go
Background
C57BL/6JCya
NCBI ID
14176
Modification
Conventional knockout
Chromosome
5
Phenotype
MGI:95519
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Fgf5em1/Cya mice (Catalog S-KO-02044) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000031280
NCBI RefSeq
NM_010203
Target Region
Exon 1
Size of Effective Region
~5.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Fgf5, a member of the fibroblast growth factor family, functions as a negative regulator of the hair cycle in mammals. It is expressed in the outer root sheath of hair follicles during the late anagen phase, mediating the transition from the anagen growth phase to the catagen regression phase. It also interacts with various signaling pathways, such as the Hedgehog (Hh) signaling pathway in the developing prostate [1].

Spontaneous and engineered FGF5 mutations in mammalian animal models result in long hair phenotypes, and in humans, inherited FGF5 mutations lead to trichomegaly (long eyelashes). Functional studies in other cancer models suggest FGF5 overexpression is an oncogenic driver. For example, in osteosarcoma, FGF5 is overexpressed and promotes cell proliferation by activating the MAPK signaling pathway. In nasopharyngeal carcinoma, cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis and decrease cisplatin sensitivity [1,4,5,6].

In addition, FGF5 has protective effects in some injury models. In endothelial cells exposed to lipopolysaccharide (LPS), FGF5 alleviates acute lung injury via the AKT signal pathway. It also protects the heart from sepsis injury by attenuating cardiomyocyte pyroptosis through inhibiting CaMKII/NFκB signaling [3,7].

In conclusion, Fgf5 is a crucial regulator in multiple biological processes, especially in the hair cycle. Its role in various diseases, such as cancer and injury-related conditions, has been revealed through functional studies in different models. Understanding Fgf5 may provide new therapeutic strategies for these diseases.

References:

1. Carrion, Evelyn A, Moses, Malcolm M, Behringer, Richard R. 2023. FGF5. In Differentiation; research in biological diversity, 139, 100736. doi:10.1016/j.diff.2023.10.004. https://pubmed.ncbi.nlm.nih.gov/37957094/

2. Stangis, Mary M, Colah, Avan N, McLean, Dalton T, Collier, Lara S, Ricke, William A. 2023. Potential roles of FGF5 as a candidate therapeutic target in prostate cancer. In American journal of clinical and experimental urology, 11, 452-466. doi:. https://pubmed.ncbi.nlm.nih.gov/38148937/

3. Li, Yuhua, Cui, Shengyu, Wu, Bing, Zhang, Furong, Xia, Hao. 2022. FGF5 alleviated acute lung injury via AKT signal pathway in endothelial cells. In Biochemical and biophysical research communications, 634, 152-158. doi:10.1016/j.bbrc.2022.09.112. https://pubmed.ncbi.nlm.nih.gov/36244113/

4. Amano, Ryo, Namekata, Masato, Horiuchi, Masataka, Yamamoto, Masakuni, Sakamoto, Taiichi. 2021. Specific inhibition of FGF5-induced cell proliferation by RNA aptamers. In Scientific reports, 11, 2976. doi:10.1038/s41598-021-82350-w. https://pubmed.ncbi.nlm.nih.gov/33536494/

5. Liu, Feng, Tang, Ling, Liu, Huai, Wang, Hui, Chen, Pan. 2024. Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2. In Cell death & disease, 15, 279. doi:10.1038/s41419-024-06671-0. https://pubmed.ncbi.nlm.nih.gov/38637504/

6. Han, Dunxin, Wang, Mingming, Yu, Zhongkai, Ren, Zhongwu, Yin, Jun. 2019. FGF5 promotes osteosarcoma cells proliferation via activating MAPK signaling pathway. In Cancer management and research, 11, 6457-6466. doi:10.2147/CMAR.S200234. https://pubmed.ncbi.nlm.nih.gov/31372048/

7. Cui, Shengyu, Li, Yuhua, Zhang, Xutao, Xia, Hao, Xu, Lin. 2022. FGF5 protects heart from sepsis injury by attenuating cardiomyocyte pyroptosis through inhibiting CaMKII/NFκB signaling. In Biochemical and biophysical research communications, 636, 104-112. doi:10.1016/j.bbrc.2022.10.080. https://pubmed.ncbi.nlm.nih.gov/36368152/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest